Evaluating the Evidence behind Policy Mandates in US Dialysis Care.
作者信息
Erickson Kevin F, Winkelmayer Wolfgang C
机构信息
Department of Medicine, Selzman Institute for Kidney Health, Section of Nephrology, and
Department of Medicine, Center for Innovations in Quality, Effectiveness, and Safety, Baylor College of Medicine, Houston, Texas; and.
出版信息
J Am Soc Nephrol. 2018 Dec;29(12):2777-2779. doi: 10.1681/ASN.2018090905. Epub 2018 Nov 2.
Abstract
摘要
相似文献
1
Evaluating the Evidence behind Policy Mandates in US Dialysis Care.评估美国透析护理政策指令背后的证据。
J Am Soc Nephrol. 2018 Dec;29(12):2777-2779. doi: 10.1681/ASN.2018090905. Epub 2018 Nov 2.
2
Futuristic plans for ESRD--a new bundled payment system.终末期肾病的未来规划——一种新的捆绑支付系统。
Nephrol News Issues. 2005 Sep;19(10):52, 54.
3
End stage renal disease and Medicare.终末期肾病与医疗保险
Health Care Financ Rev. 2003 Summer;24(4):1-5.
4
Medicare and erythropoietin.
N Engl J Med. 2007 Jan 4;356(1):4-6. doi: 10.1056/NEJMp068296.
5
Conditions for coverage fail to relieve administrative burden.承保条件未能减轻行政负担。
Nephrol News Issues. 2005 Sep;19(10):46-7, 51.
6
Bundled payment for ESRD--including ESAs in Medicare's dialysis package.终末期肾病的捆绑支付——医疗保险透析套餐中包括促红细胞生成素类似物。
N Engl J Med. 2011 Feb 17;364(7):593-5. doi: 10.1056/NEJMp1014187.
7
Medicare program; end-stage renal disease prospective payment system. Final rule.医疗保险计划；终末期肾病前瞻性支付系统。最终规则。
Fed Regist. 2010 Aug 12;75(155):49029-214.
8
Palliative dialysis in end-stage renal disease.终末期肾病的姑息性透析
Am J Hosp Palliat Care. 2011 Dec;28(8):539-42. doi: 10.1177/1049909111400061. Epub 2011 Mar 10.
9
Important legal, regulatory issues impacting renal care in 2008.2008年影响肾脏护理的重要法律、监管问题。
Nephrol News Issues. 2008 Dec;22(13):48-9.
10
Special treatment--the story of Medicare's ESRD entitlement.特殊待遇——医疗保险的终末期肾病权益历程
N Engl J Med. 2011 Feb 17;364(7):596-8. doi: 10.1056/NEJMp1014193.
引用本文的文献
1
National Trends in Complications of Vascular Access for Hemodialysis and Analysis of Racial Disparities Among Patients With End-Stage Renal Disease in the Inpatient Setting.住院环境下血液透析血管通路并发症的全国趋势及终末期肾病患者种族差异分析
Kidney Int Rep. 2023 Mar 20;8(6):1162-1169. doi: 10.1016/j.ekir.2023.03.001. eCollection 2023 Jun.
2
The authority of courage and compassion: Healthcare policy leadership in addressing the kidney disease public health epidemic.勇气与同情的权威：在应对肾脏疾病公共卫生流行中，医疗保健政策领导力。
Semin Dial. 2020 Jan;33(1):35-42. doi: 10.1111/sdi.12849. Epub 2020 Jan 9.
3
Rationale and design of a multicenter Chronic Kidney Disease (CKD) and at-risk for CKD electronic health records-based registry: CURE-CKD.多中心慢性肾脏病（CKD）和 CKD 高危电子病历为基础的登记研究：CURE-CKD 的原理和设计。
BMC Nephrol. 2019 Nov 20;20(1):416. doi: 10.1186/s12882-019-1558-9.
本文引用的文献
1
Evidence-Based Health Policy.循证卫生政策
N Engl J Med. 2017 Dec 21;377(25):2413-2415. doi: 10.1056/NEJMp1709816.
2
Hemodialysis Hospitalizations and Readmissions: The Effects of Payment Reform.血液透析住院与再入院：支付改革的影响
Am J Kidney Dis. 2017 Feb;69(2):237-246. doi: 10.1053/j.ajkd.2016.08.033. Epub 2016 Nov 14.
3
Epoetin Alfa and Outcomes in Dialysis amid Regulatory and Payment Reform.促红细胞生成素α与监管及支付改革背景下的透析治疗结局
J Am Soc Nephrol. 2016 Oct;27(10):3129-3138. doi: 10.1681/ASN.2015111232. Epub 2016 Feb 25.
4
Medicare Reimbursement Reform for Provider Visits and Health Outcomes in Patients on Hemodialysis.血液透析患者门诊就诊及健康结局的医疗保险报销改革
Forum Health Econ Policy. 2014 Jan 1;17(1):53-77. doi: 10.1515/fhep-2012-0018.
5
Provider visit frequency and vascular access interventions in hemodialysis.血液透析中医疗服务提供者的就诊频率及血管通路干预措施
Clin J Am Soc Nephrol. 2015 Feb 6;10(2):269-77. doi: 10.2215/CJN.05540614. Epub 2015 Jan 13.
6
Provider Visits and Early Vascular Access Placement in Maintenance Hemodialysis.维持性血液透析中的医疗服务提供者访视与早期血管通路置入
J Am Soc Nephrol. 2015 Aug;26(8):1990-7. doi: 10.1681/ASN.2014050464. Epub 2014 Dec 1.
7
Physician visits and 30-day hospital readmissions in patients receiving hemodialysis.接受血液透析患者的门诊就诊及30天内再入院情况
J Am Soc Nephrol. 2014 Sep;25(9):2079-87. doi: 10.1681/ASN.2013080879. Epub 2014 May 8.
8
Blood transfusion practices in dialysis patients in a dynamic regulatory environment.血液透析患者在动态监管环境中的输血实践。
Am J Kidney Dis. 2014 Oct;64(4):616-21. doi: 10.1053/j.ajkd.2014.01.011. Epub 2014 Feb 19.
9
Variation in nephrologist visits to patients on hemodialysis across dialysis facilities and geographic locations.透析机构和地理位置之间血液透析患者接受肾科医生就诊的差异。
Clin J Am Soc Nephrol. 2013 Jun;8(6):987-94. doi: 10.2215/CJN.10171012. Epub 2013 Feb 21.
10
Association of provider-patient visit frequency and patient outcomes on hemodialysis.血液透析患者的医护就诊频次与患者结局的相关性研究。
J Am Soc Nephrol. 2012 Sep;23(9):1560-7. doi: 10.1681/ASN.2012010051. Epub 2012 Jul 12.
Zotero 插件